Data / Form D filings / Selah Genomics Inc.
Selah Genomics Inc.: Form D filings
Selah Genomics Inc., a biotechnology company in Greenville, SC, filed 2 Form D notices with the SEC between 2013 and 2016. The latest, on March 7, 2016, reports $450,000 sold of a $3 million offering to 4 investors.
Find out what Selah Genomics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 411 UNIVERSITY RIDGE, SUITE A, Greenville, SC, 29601
- Phone
- (864) 751-4815
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1578094
The full lists. Form D filings in South Carolina: 341 rows, $17.05, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 7, 2016 | New notice | $3,000,000 | $450,000 | $2,550,000 | 4 | Feb 23, 2016 | sec.gov |
| May 29, 2013 | New notice | $900,000 | $300,000 | $600,000 | 2 | May 22, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael S. Bolick | Executive Officer, Director | |
| Jeremy S. Stuart | Executive Officer |
Every Form D from the week of Mar 7, 2016 · All recent filings in South Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Selah Genomics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.